- Home
- MBC vs SDGR Comparison
MBC vs SDGR Comparison
Compare MBC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- SDGR
- Stock Information
- Founded
- MBC 1954
- SDGR 1990
- Country
- MBC United States
- SDGR United States
- Employees
- MBC N/A
- SDGR N/A
- Industry
- MBC Agricultural Chemicals
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- MBC Industrials
- SDGR Health Care
- Exchange
- MBC Nasdaq
- SDGR Nasdaq
- Market Cap
- MBC 1.8B
- SDGR 1.8B
- IPO Year
- MBC N/A
- SDGR 2020
- Fundamental
- Price
- MBC $11.84
- SDGR $26.07
- Analyst Decision
- MBC Strong Buy
- SDGR Buy
- Analyst Count
- MBC 1
- SDGR 7
- Target Price
- MBC $19.00
- SDGR $33.00
- AVG Volume (30 Days)
- MBC 954.8K
- SDGR 1.6M
- Earning Date
- MBC 05-06-2025
- SDGR 05-07-2025
- Dividend Yield
- MBC N/A
- SDGR N/A
- EPS Growth
- MBC N/A
- SDGR N/A
- EPS
- MBC 0.96
- SDGR N/A
- Revenue
- MBC $2,700,400,000.00
- SDGR $207,539,000.00
- Revenue This Year
- MBC $5.06
- SDGR $24.12
- Revenue Next Year
- MBC $5.11
- SDGR $18.60
- P/E Ratio
- MBC $12.35
- SDGR N/A
- Revenue Growth
- MBC N/A
- SDGR N/A
- 52 Week Low
- MBC $10.84
- SDGR $16.60
- 52 Week High
- MBC $20.67
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- MBC 44.34
- SDGR 63.81
- Support Level
- MBC $10.88
- SDGR $25.28
- Resistance Level
- MBC $11.97
- SDGR $27.27
- Average True Range (ATR)
- MBC 0.72
- SDGR 2.08
- MACD
- MBC 0.04
- SDGR 0.59
- Stochastic Oscillator
- MBC 52.91
- SDGR 89.69
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.